Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Missak Haigentz
AIDS Malignancy Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Ucla Center for Clinical Aids Research and Education
Los Angeles, California, United States
- Uc San Diego Medical Center - Hillcrest
San Diego, California, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Louisiana State University
Lafayette, Louisiana, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Boston Medical Center
Boston, Massachusetts, United States
- Siteman Cancer Center at Washington University
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Montefiore Medical Center - Moses Campus
The Bronx, New York, United States
- Montefiore Medical Center-Einstein Campus
The Bronx, New York, United States
- Montefiore Medical Center-Weiler Hospital
The Bronx, New York, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Baylor College of Medicine/dan L Duncan Comprehensive Cancer Center
Houston, Texas, United States
- Ben Taub General Hospital
Houston, Texas, United States
- Thomas Street Clinic
Houston, Texas, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Harborview Medical Center
Seattle, Washington, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Jun 2013
- Primary completion
- 22 May 2019
- Completion
- 12 May 2021
- Last update posted
- 10 Jan 2023
- Registered enrollment
- 36
- Registry id
- NCT01822522
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.